Evidence map›Paper›PMID 35198093›Full record

ArticleOxidative medicine and cellular longevity2022

Jayasinghe A N Sandamali, Ruwani P Hewawasam, Kamani A P W Jayatilaka, Lakmini K B Mudduwa

Abstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. The Leaf Aqueous and Ethanolic Extracts ofAdvances in pharmacological and pharmaceutical sciences · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Mitochondrial Amount Determines Doxorubicin-Induced Cardiotoxicity in Cardiomyocytes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. International journal of molecular sciences · 2024
    Article
  7. Cardioprotective Effect ofMolecules (Basel, Switzerland) · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jayasinghe A N SandamaliDepartment of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Ruhuna, 80000, Sri Lanka.ORCID https://orcid.org/0000-0002-3491-9600
Ruwani P HewawasamDepartment of Biochemistry, Faculty of Medicine, University of Ruhuna, 80000, Sri Lanka.ORCID https://orcid.org/0000-0001-6349-4755
Kamani A P W JayatilakaDepartment of Biochemistry, Faculty of Medicine, University of Ruhuna, 80000, Sri Lanka.ORCID https://orcid.org/0000-0002-6714-0273
Lakmini K B MudduwaDepartment of Pathology, Faculty of Medicine, University of Ruhuna, 80000, Sri Lanka.ORCID https://orcid.org/0000-0002-0825-0552

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The therapeutic efficacy of anthracycline antibiotic, doxorubicin (Dox), is hampered due to the dose-dependent cardiotoxicity. The objective of the study was to explore the counteraction of aqueous bark extract of

Indexed as

AnimalsAntibiotics, AntineoplasticAntioxidantsApoptosisCardiotonic AgentsCardiotoxicityDNA FragmentationDose-Response Relationship, DrugDoxorubicinInflammationMyocytes, CardiacOxidative StressPlant BarkPlant ExtractsRatsRats, WistarAntibiotics, AntineoplasticAntioxidantsCardiotonic AgentsDoxorubicinPlant Extracts

Identifiers

PMID35198093
PMCPMC8860544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.